Log in
Enquire now
Centauri Therapeutics

Centauri Therapeutics

Developer of immunotherapy for the treatment of infectious diseases.

OverviewStructured DataIssuesContributors

Contents

centauritherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Biotechnology
Biotechnology
Drug discovery
Drug discovery
Biomedical engineering
Biomedical engineering
Health technology
Health technology
Location
United Kingdom
United Kingdom
CEO
Jennifer Schneider
Jennifer Schneider
Pitchbook URL
pitchbook.com/profiles...152139-16
Number of Employees (Ranges)
1 – 10
Email Address
info@centauritherapys.com
Investors
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
‌
PACE-AMR
Carb-X
Carb-X
‌
AMR Action Fund
Founded Date
2015
Total Funding Amount (USD)
46,350,000
38,350,000
Latest Funding Round Date
February 24, 2026
July 29, 2025
CFO
‌
Samantha Macro
Latest Funding Type
Series A
Series A
Country
United Kingdom
United Kingdom
Headquarters
London
London

Other attributes

Company Operating Status
Active
Investment
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Carb-X
Carb-X
Evotec
Evotec
Latest Funding Round Amount (USD)
8,000,000
5,100,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Centauri Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us